SilicoLife, the Portuguese firm designing optimised microorganisms and novel pathways for biotech applications, has just concluded two Series A fundraising rounds to the total tune of â9.8 million to be invested in 'unmet needs' within the dietary supplements industry.
Read more about it via https://www.nutraingredients.com/Article/2022/12/15/silicolife-raises-9.8m-to-invest-in-biotech-for-supplements?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS
No comments:
Post a Comment